GMRE:NYE-Global Medical REIT Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 8.77

Change

-0.03 (-0.34)%

Market Cap

N/A

Volume

0.36M

Analyst Target

USD 14.79
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

-1.29 (-0.85%)

USD 94.56B
VTR Ventas Inc

-0.56 (-0.81%)

USD 29.24B
DOC Healthpeak Properties Inc

-0.04 (-0.20%)

USD 14.30B
CTRE CareTrust REIT Inc.

+0.08 (+0.28%)

USD 4.68B
AHR American Healthcare REIT, Inc.

-0.32 (-1.08%)

USD 4.18B
NHI National Health Investors Inc

+0.57 (+0.76%)

USD 3.43B
LTC LTC Properties Inc

-0.35 (-0.97%)

USD 1.64B
UHT Universal Health Realty Income..

-0.12 (-0.29%)

USD 0.54B
CHCT Community Healthcare Trust Inc

-0.19 (-1.02%)

USD 0.52B
GMRE-PA Global Medical REIT Inc

-0.08 (-0.32%)

USD 0.41B

ETFs Containing GMRE

KBWY Invesco KBW Premium Yield.. 0.00 % 0.35 %

-0.07 (0%)

USD 0.22B
SDEF 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.60% 73% C 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.60% 73% C 91% A-
Trailing 12 Months  
Capital Gain 0.57% 20% F 44% F
Dividend Return 9.63% 93% A 94% A
Total Return 10.21% 20% F 68% D+
Trailing 5 Years  
Capital Gain -5.09% 38% F 16% F
Dividend Return 44.81% 46% F 79% B-
Total Return 39.72% 38% F 28% F
Average Annual (5 Year Horizon)  
Capital Gain -4.77% 36% F 13% F
Dividend Return 2.03% 36% F 31% F
Total Return 6.79% 86% B+ 91% A-
Risk Return Profile  
Volatility (Standard Deviation) 25.12% 43% F 43% F
Risk Adjusted Return 8.06% 36% F 26% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.